首页 | 本学科首页   官方微博 | 高级检索  
     

银杏二萜内酯葡胺联合曲克芦丁治疗急性脑梗死的临床研究
引用本文:冯艳,祁亚伟,樊晓蕊,袁丽品. 银杏二萜内酯葡胺联合曲克芦丁治疗急性脑梗死的临床研究[J]. 现代药物与临床, 2021, 36(8): 1687-1691
作者姓名:冯艳  祁亚伟  樊晓蕊  袁丽品
作者单位:河南省人民医院 神经内科,河南 郑州 450000
摘    要:目的 探讨银杏二萜内酯葡胺联合曲克芦丁治疗急性脑梗死患者的临床疗效.方法 选取2020年1月—2020年10月于河南省人民医院治疗的182例急性脑梗死患者,随机分为对照组和治疗组,每组各91例.对照组静脉滴注注射用曲克芦丁,0.48 g加入5%葡萄糖注射液250 mL,1次/d;治疗组患者在对照组基础上静脉滴注银杏二萜...

关 键 词:银杏二萜内酯葡胺注射液  注射用曲克芦丁  急性脑梗死  脑血流速度  氧化应激  神经损伤
收稿时间:2021-02-06

Clinical study on Yinxing Ertie Neizhi Puan combined with troxerutin in treatment of acute cerebral infarction
FENG Yan,QI YA-wei,FAN Xiao-rui,YUAN Li-pin. Clinical study on Yinxing Ertie Neizhi Puan combined with troxerutin in treatment of acute cerebral infarction[J]. Drugs & Clinic, 2021, 36(8): 1687-1691
Authors:FENG Yan  QI YA-wei  FAN Xiao-rui  YUAN Li-pin
Affiliation:Department of Neurology, Henan Provincial People''s Hospital, Zhengzhou 450000, China
Abstract:Objective To investigate the clinical efficacy of Yinxing Ertie Neizhi Puan combined with troxerutin in treatment of acute cerebral infarction. Methods Patients (182 cases) with acute cerebral infarction in Henan Provincial People''s Hospital from January 2020 to October 2020 were randomly divided into control and treatment groups, and each group had 91 cases. Patients in the control group were iv administered with Troxerutin for injection, 0.48 g added into 5% glucose injection 250 mL, once daily. Patients in the treatment group were iv administered with Yinxing Ertie Neizhi Puan Injection on the basis of the control group, 25 mg added into normal saline 250 mL, once daily. Patients in two groups were treated for 2 weeks. After treatment, the clinical efficacy was evaluated, and the NIHSS score, the MBI score, the cerebral blood flow velocity, the serum oxidative stress indexes, and the levels of nerve injury markers in two groups before and after treatment were compared. Results After treatment, the clinical effective rate in the control group was 82.42%, which was significantly lower than 92.31% in the treatment group (P < 0.05). After treatment, the NIHSS score in two groups was significantly lower than that before treatment, while the MBI score was significantly higher than that before treatment (P < 0.05), and the improvement was more significant in the treatment group (P < 0.05). After treatment, the levels of ACA, MCA, PCA, BA and VA in two groups were significantly higher than those before treatment (P < 0.05), especially in the treatment group (P < 0.05). After treatment, the levels of SOD and GSH-Px in two groups were significantly higher than those before treatment, while the level of MDA were significantly decreased (P < 0.05), and the above-mentioned serum oxidative stress indexes were improved more significantly in the treatment group (P < 0.05). After treatment, the levels of NPY and NSE in two groups were significantly lower than those before treatment (P < 0.05), especially in the treatment group (P < 0.05). Conclusion Yinxing Ertie Neizhi Puan combined with troxerutin can significantly improve the clinical symptoms of patients with acute cerebral infarction, can improve cerebral blood flow velocity, effectively inhibit oxidative stress reaction, reduce brain injury, and has good clinical effect and high safety.
Keywords:Yinxing Ertie Neizhi Puan Injection  Troxerutin for injection  acute cerebral infarction  cerebral blood flow velocity  oxidative stress  nerve injury
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《现代药物与临床》浏览原始摘要信息
点击此处可从《现代药物与临床》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号